Related Experiment Videos
Thromboembolic disease in patients undergoing total knee replacement
The Journal of Bone and Joint Surgery. American Volume
|October 1, 1976
Summary
Aspirin significantly reduces deep vein thrombosis (DVT) risk after total knee replacement. Patients taking aspirin had an 11% DVT incidence, compared to 88% in those not taking antiplatelet drugs.
Area of Science:
- Orthopedic Surgery
- Vascular Surgery
- Pharmacology
Background:
- Deep vein thrombosis (DVT) is a significant complication following total knee replacement (TKR).
- Thromboembolic events pose a risk to patient recovery and outcomes.
Purpose of the Study:
- To investigate the incidence of DVT in patients undergoing TKR.
- To evaluate the prophylactic effect of aspirin on thromboembolic disease in this patient cohort.
Main Methods:
- Prospective study involving 30 patients undergoing TKR.
- Clinical examinations, 125I fibrinogen scanning, and venography for suspected DVT.
- Comparison of thromboembolism incidence between aspirin users and non-users.
Main Results:
- Overall thromboembolic disease incidence was 53% (16 out of 30 patients).
- Aspirin users (n=9) had an 11% incidence of thromboembolism.
- Non-aspirin users (n=8) had an 88% incidence of thromboembolism (p=0.003).
Conclusions:
- Aspirin demonstrates a highly significant protective effect against DVT post-TKR.
- Regular aspirin use may be an effective strategy to reduce thromboembolic complications after total knee replacement.